SRF388 inhibits hepatocellular carcinoma tumor growth as a single agent in a preclinical model SRF114 induces destruction of tumor Tregs...
FREDERICK, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ) is a global company specializing in...
Jushi Europe begins development of best-in-class, sustainable greenhouse cultivation facility BOCA RATON, Fla., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Jushi...
Results demonstrated that ADAIR had slower absorption and lower early exposure, and was less desirable to recreational drug abusers on...
CMP-001 in combination with pembrolizumab continues to demonstrate durable responses in anti-PD-1 refractory melanoma in ongoing trial Encouraging new data on...
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced...
Revenue remained strong in Q3 Castellum, Inc. (OTC: ONOV) announces filing its third quarter (Q3) operating results. Revenue for Q3...
IND filing today for STI-2020 (COVI-AMG™) for the treatment of COVID-19 in patients with mild symptoms and a separate safety...
MONTREAL, Nov. 09, 2020 (GLOBE NEWSWIRE) -- ATW Tech Inc. (the "Company" or "ATW Tech") (TSX-V: ATW) is pleased to...
VANCOUVER, British Columbia, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Nextleaf Solutions Ltd. ("Nextleaf Solutions", "OILS", or the "Company") (CSE: OILS)...
Nation’s Largest Vaccine Manufacturer Spearheading Initiative BOWIE, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider...
Company to host conference call and webcast on Thursday, November 19 at 8:30 am EDT LYON, France, November 9, 2020...
KANSAS CITY, Mo., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Today, Cerner Corporation (NASDAQ: CERN), a global health care technology company,...
Conference call to be held at 8:00 AM Eastern Time on Tuesday, November 17th, 2020 MONTREAL, Nov. 09, 2020 (GLOBE...
GOLETA, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency,...
‒ Company Expects to Report Interim 3 Month Biomarker Data for All Enrolled Patients in Q1:21 with Final Bone Mineral Density,...
- Data Suggest Montelukast May Inhibit Mental Decline, Higher Doses Optimal for Clinical Trials Assessing Impact on Neurological Disease -...
WALTHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the...
NEW YORK and SYDNEY, Australia, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the...
Company Launches Two IONM-Related Clinical Research Projects DENVER, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or...